Skip to main content
Have a personal or library account? Click to login
Nicotine Is Not a Proinflammatory Component of E-cigarette Vapor Cover

Nicotine Is Not a Proinflammatory Component of E-cigarette Vapor

Open Access
|Aug 2026

References

  1. Centers for Disease Control and Prevention (CDC): Website - National Health Interview Survey : 2022 NHIS Questionnaires, Datasets, and Documentation; CDC, Atlanta, GA, USA, last updated November 20, 2024. Available at: https://www.cdc.gov/nchs/nhis/documentation/2022-nhis.html (accessed July 12, 2026).
  2. Karban, A. and R. Eliakim: Effect of Smoking on Inflammatory Bowel Disease: Is It Disease or Organ Specific?; World J. Gastroenterol. 13 (2007) 2150–2152. DOI: 10.3748/wjg.v13.i15.2150
  3. Mínguez, A. and P. Nos: Association of Smoking and Crohn's Disease: An Update; J. Cell. Immunol. 6 (2024) 140–147. DOI: 10.33696/immunology.6.200
  4. Masuko, K.: Cigarette Smoking: A Modifiable Environmental Factor in the Pathogenesis of Rheumatoid Arthritis; JMA J. 8 (2025) 1077–1086. DOI: 10.31662/jmaj.2025-0029
  5. Rothbard, J.B., J.J. Rothbard, L. Soares, C.G. Fathman, and L. Steinman: Identification of a Common Immune Regulatory Pathway Induced by Small Heat Shock Proteins, Amyloid Fibrils, and Nicotine; Proc. Natl. Acad. Sci. U.S.A. 115 (2018) 7081–7086. DOI: 10.1073/pnas.1804599115
  6. Zhang, W., H. Lin, M. Zou, Q. Yuan, Z. Huang, X. Pan, and W. Zhang: Nicotine in Inflammatory Diseases: Anti-Inflammatory and Pro-Inflammatory Effects; Front. Immunol. 13 (2022) 826889. DOI: 10.3389/fimmu.2022.826889
  7. Cao, Y., J. Sun, X. Wang, X. Zhang, H. Tian, L. Huang, Z. Huang, Y. Zhang, J. Zhang, L. Li, and S. Zhou: The Double-Edged Nature of Nicotine: Toxicities and Therapeutic Potentials; Front. Pharmacol. 15 (2024) 1427314. DOI: 10.3389/fphar.2024.1427314
  8. Liu, Y., G. Cheng, J. Cao, J. Zhang, C. Luo, and L. Huang: The “Double-Edged Sword Effect” of Nicotine; Fitoterapia 177 (2024) 106102. DOI: 10.1016/j.fitote.2024.106102
  9. Scherer, G., N. Pluym, and M. Scherer: Literature Review on Nicotine’s Role in Human Health; Contrib. Tob. Nicotine Res. 33 (2024) 1–111. DOI: 10.2478/cttr-2024-0001
  10. Lee, Y.H., M. Gawron, and M.L. Goniewicz: Changes in Puffing Behavior among Smokers Who Switched from Tobacco to Electronic Cigarettes; Addict. Behav. 48 (2015) 1–4. DOI: 10.1016/j.addbeh.2015.04.003
  11. Perfetti, T.A. and A. Rodgman: The Complexity of Tobacco and Tobacco Smoke; Beitr. Tabakforsch. Int. 24 (2011) 215–232. DOI: 10.2478/cttr-2013-0902
  12. Borgerding, M. and H. Klus: Analysis of Complex Mixtures – Cigarette Smoke; Exp. Toxicol. Pathol. 57 (2005) 43–73. DOI: 10.1016/j.etp.2005.05.010
  13. Rennard, S. and D. Daughton: Smoking Reduction and Biological Markers of Response; Monaldi Arch. Chest Dis. 48 (1993) 580–582.
  14. Perricone, R., C. de Carolis, G. de Sanctis, and L. Fontana: Complement Activation by Cigarette Smoke Condensate and Tobacco Infusion; Arch. Environ. Health 38 (1983) 176–179. DOI: 10.1080/00039896.1983.10544001
  15. Kew, R.R., B. Ghebrehiwet, and A. Janoff: The Fifth Component of Complement (C5) Is Necessary for Maximal Pulmonary Leukocytosis in Mice Chronically Exposed to Cigarette Smoke; Clin. Immunol. Immunopathol. 43 (1987) 73–81. DOI: 10.1016/0090-1229(87)90158-9
  16. Robbins, R.A., G.L. Gossman, K.J. Nelson, S. Koyama, A.B. Thompson, and S.I. Rennard: Inactivation of Chemotactic Factor Inactivator by Cigarette Smoke. A Potential Mechanism of Modulating Neutrophil Recruitment to the Lung; Am. Rev. Respir. Dis. 142 (1990) 763–768. DOI: 10.1164/ajrccm/142.4.763
  17. Hunninghake, G.W. and R.G. Crystal: Cigarette Smoking and Lung Destruction. Accumulation of Neutrophils in the Lungs of Cigarette Smokers; Am. Rev. Respir. Dis. 128 (1983) 833–838. DOI: 10.1164/arrd.1983.128.5.833
  18. Shoji, S., R.F. Ertl, S. Koyama, R. Robbins, G. Leikauf, S. Von Essen, and S.I. Rennard: Cigarette Smoke Stimulates Release of Neutrophil Chemotactic Activity from Cultured Bovine Bronchial Epithelial Cells; Clin. Sci. 88 (1995) 337–344. DOI: 10.1042/cs0880337
  19. Mio, T., D.J. Romberger, A.B. Thompson, R.A. Robbins, A. Heires, and S.I. Rennard: Cigarette Smoke Induces Interleukin-8 Release from Human Bronchial Epithelial Cells; Am. J. Respir. Crit. Care Med. 155 (1997) 1770–1776. DOI: 10.1164/ajrccm.155.5.9154890
  20. Fujita, J., N.L. Nelson, D.M. Daughton, C.A. Dobry, J.R. Spurzem, S. Irino, and S.I. Rennard: Evaluation of Elastase and Antielastase Balance in Patients with Chronic Bronchitis and Pulmonary Emphysema; Am. Rev. Respir. Dis. 142 (1990) 57–62. DOI: 10.1164/ajrccm/142.1.57
  21. Carp, H., F. Miller, J.R. Hoidal, and A. Janoff: Potential Mechanism of Emphysema: a1-Proteinase Inhibitor Recovered from Lungs of Cigarette Smokers Contains Oxidized Methionine and Has Decreased Elastase Inhibitory Capacity; Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 2041–2045. DOI: 10.1073/pnas.79.6.2041
  22. Hubbard, R.C., F. Ogushi, G.A. Fells, A.M. Cantin, S. Jallat, M. Courtney, and R.G. Crystal: Oxidants Spontaneously Released by Alveolar Macrophages of Cigarette Smokers Can Inactivate the Active Site of Alpha 1-Antitrypsin, Rendering It Ineffective as an Inhibitor of Neutrophil Elastase; J. Clin. Invest. 80 (1987) 1289–1295. DOI: 10.1172/JCI113204
  23. Shapiro, S.D.: Elastolytic Metalloproteinases Produced by Human Mononuclear Phagocytes: Potential Roles in Destructive Lung Disease; Am. J. Respir. Crit. Care Med. 150 (1994) S160–S164. DOI: 10.1164/ajrccm/150.6_Pt_2.S160
  24. Hunninghake, G.W., J.M. Davidson, S. Rennard, S. Szapiel, J.E. Gadek, and R.G. Crystal: Elastin Fragments Attract Macrophage Precursors to Diseased Sites in Pulmonary Emphysema; Science 212 (1981) 925–927. DOI: 10.1126/science.7233186
  25. Senior, R.M., G.L. Griffin, and R.P. Mecham: Chemotactic Activity of Elastin-Derived Peptides; J. Clin. Invest. 66 (1980) 859–862. DOI: 10.1172/JCI109926
  26. Chang, J.C., M. Lesser, O.H. Yoo, and M. Orlowski: Increased Cathepsin B-Like Activity in Alveolar Macrophages and Bronchoalveolar Lavage Fluid from Smokers; Am. Rev. Respir. Dis. 134 (1986) 538–541. DOI: 10.1164/arrd.1986.134.3.538
  27. Gairola, C.G., N.I. Galicki, C. Cardozo, Y.L. Lai, and M. Lesser: Cigarette Smoke Stimulates Cathepsin B Activity in Alveolar Macrophages of Rats; J. Lab. Clin. Med. 114 (1989) 419–425.
  28. Lesser, M., M.L. Padilla, and C. Cardozo: Induction of Emphysema in Hamsters by Intratracheal Instillation of Cathepsin B; Am. Rev. Respir. Dis. 145 (1992) 661–668. DOI: 10.1164/ajrccm/145.3.661
  29. Chang, J.C., O.H. Yoo, and M. Lesser: Cathepsin D Activity Is Increased in Alveolar Macrophages and Bronchoalveolar Lavage Fluid of Smokers; Am. Rev. Respir. Dis. 140 (1989) 958–960. DOI: 10.1164/ajrccm/140.4.958
  30. Lesser, M., N. Galicki, C. Cardozo, and C.G. Gariola: Cathepsin L Activity in Alveolar Macrophages of Rats: Response to Cigarette Smoke; Am. J. Respir. Cell Mol. Biol. 1 (1989) 371–376. DOI: 10.1165/ajrcmb/1.5.371
  31. Levänen, B., P. Glader, B. Dahlén, B. Billing, I. Qvarfordt, L. Palmberg, K. Larsson, and A. Lindén: Impact of Tobacco Smoking on Cytokine Signaling via Interleukin-17a in the Peripheral Airways; Int. J. Chron. Obstruct. Pulmon. Dis. 11 (2016) 2109–2116. DOI: 10.2147/COPD.S99900
  32. Elisia, I., V. Lam, B. Cho, M. Hay, M.Y. Li, M. Yeung, L. Bu, W. Jia, N. Norton, S. Lam, and G. Krystal: The Effect of Smoking on Chronic Inflammation, Immune Function and Blood Cell Composition; Sci. Rep. 10 (2020) 19480. DOI: 10.1038/s41598-020-76556-7
  33. Che, Karlhans F., E. Tufvesson, S. Tengvall, E. Lappi-Blanco, R. Kaarteenaho, B. Levänen, M. Ekberg, A. Brauner, Åsa M. Wheelock, L. Bjermer, C.M. Sköld, and A. Lindén: The Neutrophil-Mobilizing Cytokine Interleukin-26 in the Airways of Long-Term Tobacco Smokers; Clin. Sci. 132 (2018) 959–983. DOI: 10.1042/cs20180057
  34. Niewoehner, D.E., J. Kleinerman, and D.B. Rice: Pathologic Changes in the Peripheral Airways of Young Cigarette Smokers; N. Engl. J. Med. 291 (1974) 755–758. DOI: 10.1056/NEJM197410102911503
  35. Kominami, E., T. Tsukahara, K. Hara, and N. Katunuma: Biosyntheses and Processing of Lysosomal Cysteine Proteinases in Rat Macrophages; FEBS Lett. 231 (1988) 225–228. DOI: 10.1016/0014-5793(88)80736-1
  36. Jones, P.W., F.H. Quirk, and C.M. Baveystock: The St George's Respiratory Questionnaire; Respir. Med. 85 Suppl B (1991) 25–31; discussion 33–27. DOI: 10.1016/s0954-6111(06)80166-6
  37. Jones, P.W., F.H. Quirk, C.M. Baveystock, and P. Littlejohns: A Self-Complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire; Am. Rev. Respir. Dis. 145 (1992) 1321–1327. DOI: 10.1164/ajrccm/145.6.1321
  38. Barr, J.T., G.E. Schumacher, S. Freeman, M. LeMoine, A.W. Bakst, and P.W. Jones: American Translation, Modification, and Validation of the St. George's Respiratory Questionnaire; Clin. Ther. 22 (2000) 1121–1145. DOI: 10.1016/S0149-2918(00)80089-2
  39. McFadden, E.R. and D.A. Linden: A Reduction in Maximum Mid-Expiratory Flow Rate: A Spirographic Manifestation of Small Airway Disease; Am. J. Med. 52 (1972) 725–737. DOI: 10.1016/0002-9343(72)90078-2
  40. Kwon, D.S., Y.J. Choi, T.H. Kim, M.K. Byun, J.H. Cho, H.J. Kim, and H.J. Park: FEF25-75% Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease; Int. J. Chron. Obstruct. Pulmon. Dis. 15 (2020) 2913–2921. DOI: 10.2147/COPD.S261732
  41. Pisi, R., M. Aiello, A. Frizzelli, L. Calzetta, L. Marchi, G. Bertorelli, G. Pisi, and A. Chetta: Detection of Small Airway Dysfunction in Asymptomatic Smokers with Preserved Spirometry: The Value of the Impulse Oscillometry System; Int. J. Chron. Obstruct. Pulmon. Dis. 16 (2021) 2585–2590. DOI: 10.2147/COPD.S319972
  42. Coates, G. and H. O'Brodovich: Measurement of Pulmonary Epithelial Permeability with 99mTc-DTPA Aerosol; Semin. Nucl. Med. 16 (1986) 275–284. DOI: 10.1016/S0001-2998(86)80014-9
  43. Stewart, J.C., R.W. Hyde, J. Boscia, M.Y. Chow, R.E. O'Mara, I. Perillo, A. Pietropaoli, C.J. Smith, A. Torres, M.J. Utell, and M.W. Frampton: Changes in Markers of Epithelial Permeability and Inflammation in Chronic Smokers Switching to a Nonburning Tobacco Device (Eclipse); Nicotine Tob. Res. 8 (2006) 773–783. DOI: 10.1080/14622200601004091
  44. Rößler, G., J. Labode, J. Schipke, S.A. Tschanz, and C. Mühlfeld: Three-Dimensional Characteristics of the Alveolar Capillary Network in Infant and Adult Human Lungs; Pediatr. Res. 97 (2025) 2136–2144. DOI: 10.1038/s41390-024-03572-y
  45. Tigner, A., S.A. Ibrahim, and I.V. Murray: Website - Histology, White Blood Cell; StatPearls Publishing, Treasure Island, FL, USA, last updated February 14, 2026. Available at: https://www.ncbi.nlm.nih.gov/books/NBK563148/ (accessed June 23, 2026).
  46. Roberts, R.E. and M.B. Hallett: Neutrophil Cell Shape Change: Mechanism and Signalling during Cell Spreading and Phagocytosis; Int. J. Mol. Sci. 20 (2019) 1383. DOI: 10.3390/ijms20061383
  47. Gullberg, U., E. Andersson, D. Garwicz, A. Lindmark, and I. Olsson: Biosynthesis, Processing and Sorting of Neutrophil Proteins: Insight into Neutrophil Granule Development; Eur. J. Haaematol. 58 (1997) 137–153. DOI: 10.1111/j.1600-0609.1997.tb00940.x
  48. Vlahovic, G., M.L. Russell, R.R. Mercer, and J.D. Crapo: Cellular and Connective Tissue Changes in Alveolar Septal Walls in Emphysema; Am. J. Respir. Crit. Care Med. 160 (1999) 2086–2092. DOI: 10.1164/ajrccm.160.6.9706031
  49. Budde, R. and H.E. Schaefer: Smokers' Dysmyelopoiesis – Bone Marrow Alterations Associated with Cigarette Smoking; Pathol. Res. Pract. 185 (1989) 347–350. DOI: 10.1016/S0344-0338(89)80011-1
  50. Bain, B.J.: Bone Marrow Trephine Biopsy; J. Clin. Pathol. 54 (2001) 737–742.
  51. van Eeden, S. and J. Hogg: The Response of Human Bone Marrow to Chronic Cigarette Smoking; Eur. Respir. J. 15 (2000) 915–921. DOI: 10.1034/j.1399-3003.2000.15e18.x
  52. Linderkamp, O., P. Ruef, B. Brenner, E. Gulbins, and F. Lang: Passive Deformability of Mature, Immature, and Active Neutrophils in Healthy and Septicemic Neonates; Pediatr. Res. 44 (1998) 946–950. DOI: 10.1203/00006450-199812000-00021
  53. Demkow, U. and F.J. van Overveld: Role of Elastases in the Pathogenesis of Chronic Obstructive Pulmonary Disease: Implications for Treatment; Eur. J. Med. Res. 15 (2010) 27. DOI: 10.1186/2047-783X-15-S2-27
  54. Molet, S., C. Belleguic, H. Lena, N. Germain, C.P. Bertrand, S.D. Shapiro, J.M. Planquois, P. Delaval, and V. Lagente: Increase in Macrophage Elastase (MMP-12) in Lungs from Patients with Chronic Obstructive Pulmonary Disease; Inflamm. Res. 54 (2005) 31–36. DOI: 10.1007/s00011-004-1319-4
  55. Lee, J., V. Taneja, and R. Vassallo: Cigarette Smoking and Inflammation: Cellular and Molecular Mechanisms; J. Dent. Res. 91 (2012) 142–149. DOI: 10.1177/0022034511421200
  56. Marcilla, A., I. Martínez, D. Berenguer, A. Gómez-Siurana, and M.I. Beltrán: Comparative Study of the Main Characteristics and Composition of the Mainstream Smoke of Ten Cigarette Brands Sold in Spain; Food Chem. Toxicol. 50 (2012) 1317–1333. DOI: 10.1016/j.fct.2012.01.046
  57. Berkowitz, L., B.M. Schultz, G.A. Salazar, C. Pardo-Roa, V.P. Sebastian, M.M. Alvarez-Lobos, and S.M. Bueno: Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn's Disease and Ulcerative Colitis; Front. Immunol. 9 (2018) 74. DOI: 10.3389/fimmu.2018.00074
  58. Smith, C.J., T.A. Perfetti, R. Garg, and C. Hansch: Utility of the Mouse Dermal Promotion Assay in Comparing the Tumorigenic Potential of Cigarette Mainstream Smoke; Food Chem. Toxicol. 44 (2006) 1699–1706. DOI: 10.1016/j.fct.2006.05.008
  59. Smith, C.J., T.A. Perfetti, and J.A. King: Perspectives on Pulmonary Inflammation and Lung Cancer Risk in Cigarette Smokers; Inhal. Toxicol. 18 (2006) 667–677. DOI: 10.1080/08958370600742821
  60. Madsen, C., P. Nafstad, L. Eikvar, P.E. Schwarze, K.S. Rønningen, and L.L. Haaheim: Association between Tobacco Smoke Exposure and Levels of C-Reactive Protein in the Oslo II Study; Eur. J. Epidemiol. 22 (2007) 311–317. DOI: 10.1007/s10654-007-9121-6
  61. Kianoush, S., M.S. Bittencourt, P.A. Lotufo, I.M. Bensenor, S.R. Jones, A.P. DeFilippis, P.P. Toth, J.D. Otvos, M. Tibuakuu, M.E. Hall, P.H.N. Harada, and M.J. Blaha: Association between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil); J. Am. Heart Assoc. 6 (2017) e006545. DOI: 10.1161/JAHA.117.006545
  62. Tuut, M. and H.-W. Hense: Smoking, Other Risk Factors and Fibrinogen Levels: Evidence of Effect Modification; Ann. Epidemiol. 11 (2001) 232–238. DOI: 10.1016/S1047-2797(00)00226-X
  63. Petitti, D.B. and H. Kipp: The Leukocyte Count: Associations with Intensity of Smoking and Persistence of Effect after Quitting; Am. J. Epidemiol. 123 (1986) 89–95. DOI: 10.1093/oxfordjournals.aje.a114227
  64. Yarnell, J.W., P.M. Sweetnam, S. Rogers, P.C. Elwood, D. Bainton, I.A. Baker, R. Eastham, J.R. O'Brien, and M.D. Etherington: Some Long Term Effects of Smoking on the Haemostatic System: a Report from the Caerphilly and Speedwell Collaborative Surveys; J. Clin. Pathol. 40 (1987) 909–913. DOI: 10.1136/jcp.40.8.909
  65. Schwartz, J. and S.T. Weiss: Host and Environmental Factors Influencing the Peripheral Blood Leukocyte Count; Am. J. Epidemiol. 134 (1991) 1402–1409. DOI: 10.1093/oxfordjournals.aje.a116045
  66. Schwartz, J. and S.T. Weiss: Cigarette Smoking and Peripheral Blood Leukocyte Differentials; Ann. Epidemiol. 4 (1994) 236–242. DOI: 10.1016/1047-2797(94)90102-3
  67. Freedman, D.S., W.D. Flanders, J.J. Barboriak, A.M. Malarcher, and L. Gates: Cigarette Smoking and Leukocyte Subpopulations in Men; Ann. Epidemiol. 6 (1996) 299–306. DOI: 10.1016/s1047-2797(96)00024-5
  68. Sunyer, J., A. Muñoz, Y. Peng, J. Margolick, J.S. Chmiel, J. Oishi, L. Kingsley, and J.M. Samet: Longitudinal Relation between Smoking and White Blood Cells; Am. J. Epidemiol. 144 (1996) 734–741. DOI: 10.1093/oxfordjournals.aje.a008997
  69. van Tiel, E.D., P.H.M. Peeters, H.A. Smit, N.J.D. Nagelkerke, A.J.M. Van Loon, D.E. Grobbee, and H.B. Bueno-De-Mesquita: Quitting Smoking May Restore Hematological Characteristics within Five Years; Ann. Epidemiol. 12 (2002) 378–388. DOI: 10.1016/S1047-2797(01)00282-4
  70. Fröhlich, M., M. Sund, H. Löwel, A. Imhof, A. Hoffmeister, and W. Koenig: Independent Association of Various Smoking Characteristics with Markers of Systemic Inflammation in Men: Results from a Representative Sample of the General Population (Monica Augsburg Survey 1994/95); Eur. Heart J. 24 (2003) 1365–1372. DOI: 10.1016/s0195-668x(03)00260-4
  71. Smith, M.R., A.-L. Kinmonth, R.N. Luben, S. Bingham, N.E. Day, N.J. Wareham, A. Welch, and K.-T. Khaw: Smoking Status and Differential White Cell Count in Men and Women in the Epic-Norfolk Population; Atherosclerosis 169 (2003) 331–337. DOI: 10.1016/S0021-9150(03)00200-4
  72. Lao, X.Q., C.Q. Jiang, W.S. Zhang, P. Adab, T.H. Lam, K.K. Cheng, and G.N. Thomas: Smoking, Smoking Cessation and Inflammatory Markers in Older Chinese Men: The Guangzhou Biobank Cohort Study; Atherosclerosis 203 (2009) 304–310. DOI: 10.1016/j.atherosclerosis.2008.06.028
  73. Higuchi, T., F. Omata, K. Tsuchihashi, K. Higashioka, R. Koyamada, and S. Okada: Current Cigarette Smoking Is a Reversible Cause of Elevated White Blood Cell Count: Cross-Sectional and Longitudinal Studies; Prev. Med. Rep. 4 (2016) 417–422. DOI: 10.1016/j.pmedr.2016.08.009
  74. Zhu, Y.P., L. Padgett, H.Q. Dinh, P. Marcovecchio, A. Blatchley, R. Wu, E. Ehinger, C. Kim, Z. Mikulski, G. Seumois, A. Madrigal, P. Vijayanand, and C.C. Hedrick: Identification of an Early Unipotent Neutrophil Progenitor with Pro-Tumoral Activity in Mouse and Human Bone Marrow; Cell Rep. 24 (2018) 2329–2341.e2328. DOI: 10.1016/j.celrep.2018.07.097
  75. Ghaedi, M., Catherine A. Steer, I. Martinez-Gonzalez, Timotheus Y.F. Halim, N. Abraham, and F. Takei: Common-Lymphoid-Progenitor-Independent Pathways of Innate and T Lymphocyte Development; Cell Rep. 15 (2016) 471–480. DOI: 10.1016/j.celrep.2016.03.039
  76. Weiskopf, K., P.J. Schnorr, W.W. Pang, M.P. Chao, A. Chhabra, J. Seita, M. Feng, and I.L. Weissman: Myeloid Cell Origins, Differentiation, and Clinical Implications; in: Myeloid Cells in Health and Disease, 2016, pp. 857–875. DOI: 10.1128/9781555819194.ch50
  77. Mukhopadhyay, S., J.R. Hoidal, and T.K. Mukherjee: Role of TNFα in Pulmonary Pathophysiology; Respir. Res. 7 (2006) 125. DOI: 10.1186/1465-9921-7-125
  78. Tsantikos, E., M. Lau, C.M.N. Castelino, M.J. Maxwell, S.L. Passey, M.J. Hansen, N.E. McGregor, N.A. Sims, D.P. Steinfort, L.B. Irving, G.P. Anderson, and M.L. Hibbs: Granulocyte-CSF Links Destructive Inflammation and Comorbidities in Obstructive Lung Disease; J. Clin. Invest. 128 (2018) 2406–2418. DOI: 10.1172/JCI98224
  79. Pietras, E.M., C. Mirantes-Barbeito, S. Fong, D. Loeffler, L.V. Kovtonyuk, S. Zhang, R. Lakshminarasimhan, C.P. Chin, J.-M. Techner, B. Will, C. Nerlov, U. Steidl, M.G. Manz, T. Schroeder, and E. Passegué: Chronic Interleukin-1 Exposure Drives Haematopoietic Stem Cells Towards Precocious Myeloid Differentiation at the Expense of Self-Renewal; Nat. Cell Biol. 18 (2016) 607–618. DOI: 10.1038/ncb3346
  80. Florentin, J., J. Zhao, Y.-Y. Tai, S.B. Vasamsetti, S.P. O’Neil, R. Kumar, A. Arunkumar, A. Watson, J. Sembrat, G.C. Bullock, L. Sanders, B. Kassa, M. Rojas, B.B. Graham, S.Y. Chan, and P. Dutta: Interleukin-6 Mediates Neutrophil Mobilization from Bone Marrow in Pulmonary Hypertension; Cell. Mol. Immunol. 18 (2021) 374–384. DOI: 10.1038/s41423-020-00608-1
  81. van Eeden, S.E. and T. Terashima: Interleukin 8 (IL-8) and the Release of Leukocytes from the Bone Marrow; Leuk. Lymphoma 37 (2000) 259–271. DOI: 10.3109/10428190009089427
  82. McCormick, T.S., R.B. Hejal, L.O. Leal, and M.A. Ghannoum: GM-CSF: Orchestrating the Pulmonary Response to Infection; Front. Pharmacol. 12 (2022) 735443. DOI: 10.3389/fphar.2021.735443
  83. McGill, H.C.: Personal Communication during a Visit to the Texas Biomedical Research Institute, San Antonio, Texas; ca. 1988.
  84. Gidding, S.S., J.S. Rana, C. Prendergast, H. McGill, J.J. Carr, K. Liu, L.A. Colangelo, C.M. Loria, J. Lima, J.G. Terry, J.P. Reis, and C.A. McMahan: Pathobiological Determinants of Atherosclerosis in Youth (Pday) Risk Score in Young Adults Predicts Coronary Artery and Abdominal Aorta Calcium in Middle Age; Circulation 133 (2016) 139–146. DOI: 10.1161/CIRCULATIONAHA.115.018042
  85. Theofilis, P., M. Sagris, E. Oikonomou, A.S. Antonopoulos, G. Siasos, C. Tsioufis, and D. Tousoulis: Inflammatory Mechanisms Contributing to Endothelial Dysfunction; Biomedicines 9 (2021) 781. DOI: 10.3390/biomedicines9070781
  86. Benowitz, N.L., J. Hukkanen, and P. Jacob III: Nicotine Chemistry, Metabolism, Kinetics and Biomarkers; in: Nicotine Psychopharmacology, edited by J.E. Henningfield, E.D. London, and S. Pogun, Springer Heidelberg, Germany, 2009, pp. 29–60. DOI: 10.1007/978-3-540-69248-5_2
  87. Hukkanen, J., P. Jacob III, and N.L. Benowitz: Metabolism and Disposition Kinetics of Nicotine; Pharmacol. Rev. 57 (2005) 79–115. DOI: 10.1124/pr.57.1.3
  88. Yingst, J.M., C. Bordner, S. Hrabovsky, A.L. Hobkirk, N. Trushin, J.P. Richie, Jr., and J. Foulds: Nicotine Delivery of a Menthol-Flavored Heat-Not-Burn Tobacco Product during Directed Use; Nicotine Tob. Res. 26 (2024) 397–401. DOI: 10.1093/ntr/ntad119
  89. Philip Morris International (PMI): Website - Heated Tobacco Products; PMI, Lausanne, Switzerland, Available at: https://www.pmi.com/our-business/smoke-free-products/heated-tobacco-products (accessed June 23, 2026).
  90. Smith, M.R., B. Clark, F. Lüdicke, J.P. Schaller, P. Vanscheeuwijck, J. Hoeng, and M.C. Peitsch: Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the System and the Scientific Assessment Program; Regul. Toxicol. Pharmacol. 81 Suppl 2 (2016) S17–S26. DOI: 10.1016/j.yrtph.2016.07.006
  91. Claus, E.D., B.C. Moeller, D. Harbour, P.J. Kuehl, M. McGuire, J.C. Vivar, and M.J. Schroeder: Use Behaviors, Dependence, and Nicotine Exposure Associated with Ad Libitum Cigar Smoking; Tob. Regul. Sci. 4 (2018) 548–561. DOI: 10.18001/TRS.4.1.2
  92. Lunell, E., K. Fagerström, J. Hughes, and R. Pendrill: Pharmacokinetic Comparison of a Novel Non-Tobacco-Based Nicotine Pouch (Zyn) with Conventional, Tobacco-Based Swedish Snus and American Moist Snuff; Nicotine Tob. Res. 22 (2020) 1757–1763. DOI: 10.1093/ntr/ntaa068
  93. Renard, K., D. Nishihara, J. Nilsson, S. Larroque, J. Martinez, and L. Giles: Characterization of the Nicotine Uptake and Safety of Nordic Spirit Tobacco-Free Oral Nicotine Pouches: A Randomized Crossover Study; Psychopharmacology 242 (2025) 855–865. DOI: 10.1007/s00213-024-06721-7
  94. Digard, H., C. Proctor, A. Kulasekaran, U. Malmqvist, and A. Richter: Determination of Nicotine Absorption from Multiple Tobacco Products and Nicotine Gum; Nicotine Tob. Res. 15 (2013) 255–261. DOI: 10.1093/ntr/nts123
  95. Mallock-Ohnesorg, N., A. Rabenstein, Y. Stoll, M. Gertzen, B. Rieder, S. Malke, N. Burgmann, P. Laux, E. Pieper, T. Schulz, K. Franzen, A. Luch, and T. Ruther: Small Pouches, but High Nicotine Doses-Nicotine Delivery and Acute Effects after Use of Tobacco-Free Nicotine Pouches; Front. Pharmacol. 15 (2024) 1392027. DOI: 10.3389/fphar.2024.1392027
  96. Azzopardi, D., E. Brown, F. Meichanetzidis, S. Fiebelkorn, L.E. Haswell, G. Hardie, and M. McEwan: A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers; J. Clin. Pharmacol. 66 (2026) e70090. DOI: 10.1002/jcph.70090
  97. Pickworth, W.B., Z.R. Rosenberry, W. Gold, and B. Koszowski: Nicotine Absorption from Smokeless Tobacco Modified to Adjust pH; J. Addict Res. Ther. 5 (2014) 1000184. DOI: 10.4172/2155-6105.1000184
  98. Voos, N., L. Kaiser, M.C. Mahoney, C.M. Bradizza, L.T. Kozlowski, N.L. Benowitz, R.J. O'Connor, and M.L. Goniewicz: Randomized within-Subject Trial to Evaluate Smokers' Initial Perceptions, Subjective Effects and Nicotine Delivery across Six Vaporized Nicotine Products; Addiction 114 (2019) 1236–1248. DOI: 10.1111/add.14602
  99. Hajek, P., D. Przulj, A. Phillips, R. Anderson, and H. McRobbie: Nicotine Delivery to Users from Cigarettes and from Different Types of E-Cigarettes; Psychopharmacology 234 (2017) 773–779. DOI: 10.1007/s00213-016-4512-6
  100. Yuki, D., C. Sakaguchi, A. Kikuchi, and Y. Futamura: Pharmacokinetics of Nicotine Following the Controlled Use of a Prototype Novel Tobacco Vapor Product; Regul. Toxicol. Pharmacol. 87 (2017) 30–35. DOI: 10.1016/j.yrtph.2017.05.005
  101. Goldenson, N.I., I.M. Fearon, A.R. Buchhalter, and J.E. Henningfield: An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers; Nicotine Tob. Res. 23 (2021) 947–955. DOI: 10.1093/ntr/ntab001
  102. An Open-Label, Randomized, Crossover Study to Assess Nicotine Uptake, Tobacco-Related Biomarkers of Exposure, Biomarkers of Potential Harm, and Puff Topography with Use of Myblutm Electronic Cigarettes in Adult Smokers; 2020, Available at: https://clinicaltrials.gov/study/NCT04430634 (accessed June 23, 2026).
  103. St. Helen, G., K.C. Ross, D.A. Dempsey, C.M. Havel, P. Jacob III, and N.L. Benowitz: Nicotine Delivery and Vaping Behavior during Ad Libitum E-Cigarette Access; Tob. Regul. Sci. 2 (2016) 363–376. DOI: 10.18001/TRS.2.4.8
  104. Farsalinos, K.E., A. Spyrou, K. Tsimopoulou, C. Stefopoulos, G. Romagna, and V. Voudris: Nicotine Absorption from Electronic Cigarette Use: Comparison between First and New-Generation Devices; Sci. Rep. 4 (2014) 4133. DOI: 10.1038/srep04133
  105. Centers for Disease Control and Prevention (CDC): Website - Smoking and Tobacco Use – About E-Cigarettes (Vapes); CDC, Atlanta, GA, USA, last updated October 24, 2024. Available at: https://www.cdc.gov/tobacco/e-cigarettes/about.html (accessed June 23, 2026).
  106. Margham, J., K. McAdam, A. Cunningham, A. Porter, S. Fiebelkorn, D. Mariner, H. Digard, and C. Proctor: The Chemical Complexity of E-Cigarette Aerosols Compared with the Smoke from a Tobacco Burning Cigarette; Front. Chem. 9 (2021) 743060. DOI: 10.3389/fchem.2021.743060
  107. Wilkinson, P.J., A. Clarke, I.M. Fearon, and R. Barry: Emissions from Conventional and Electronic Waterpipes Relative to Cigarettes and a Heated Tobacco Product; Sci. Rep. 15 (2025) 14176. DOI: 10.1038/s41598-025-90721-w
  108. White, J.L., B.T. Conner, T.A. Perfetti, B.R. Bombick, J.T. Avalos, K.W. Fowler, C.J. Smith, and D.J. Doolittle: Effect of Pyrolysis Temperature on the Mutagenicity of Tobacco Smoke Condensate; Food Chem. Toxicol. 39 (2001) 499–505. DOI: 10.1016/s0278-6915(00)00155-1
  109. Rowell, T.R. and R. Tarran: Will Chronic E-Cigarette Use Cause Lung Disease?; Am. J. Physiol. Lung Cell. Mol. Physiol. 309 (2015) L1398–L1409. DOI: 10.1152/ajplung.00272.2015
  110. Cui, H., L. Zhao, M. Fan, S. Liu, L. Chen, J. Cai, Y. Qin, X. Ding, and Z. Jiang: Study on Vaporisation Temperature of Electronic Cigarette; presented at the CORESTA Meeting, Smoke Science/Product Technology, Kitzbühel, Austria, 2017, Paper STPOST 12.
  111. Chen, W., P. Wang, K. Ito, J. Fowles, D. Shusterman, P.A. Jaques, and K. Kumagai: Measurement of Heating Coil Temperature for E-Cigarettes with a “Top-Coil” Clearomizer; PLOS ONE 13 (2018) e0195925. DOI: 10.1371/journal.pone.0195925
  112. Baker, R.R.: Temperature Distribution inside a Burning Cigarette; Nature 247 (1974) 405–406. DOI: 10.1038/247405a0
  113. Baker, R.R.: Development of Temperature Distribution inside the Reaction Zone of a Burning Cigarette; in: Thermal Analysis, Volume 1, edited by H.G. Wiedemann, Birkhäuser, Basel, Switzerland, 1980, pp. 439–444. DOI: 10.1007/978-3-0348-6719-1_69
  114. Baker, R.R.: Smoke Chemistry; in: Tobacco. Production, Chemistry and Technology, edited by D.L. Davis and M.T. Nielsen, Blackwell Science, Oxford, UK, ISBN: 9780632047918, 1999, pp. 398–439.
  115. Baker, R.R.: Smoke Generation inside a Burning Cigarette: Modifying Combustion to Develop Cigarettes That May Be Less Hazardous to Health; Prog. Energy Combust. Sci. 32 (2006) 373–385. DOI: 10.1016/j.pecs.2006.01.001
  116. Rodgman, A. and T.A. Perfetti: The Chemical Components of Tobacco and Tobacco Smoke; 2nd ed., CRC Press, Boca Raton, FL, USA, 2013, 2332 pp. ISBN: 9780429096266. DOI: 10.1201/b13973
  117. Goniewicz, M.L., J. Knysak, M. Gawron, L. Kosmider, A. Sobczak, J. Kurek, A. Prokopowicz, M. Jablonska-Czapla, C. Rosik-Dulewska, C. Havel, P. Jacob III, and N. Benowitz: Levels of Selected Carcinogens and Toxicants in Vapour from Electronic Cigarettes; Tob. Control 23 (2014) 133–139. DOI: 10.1136/tobaccocontrol-2012-050859
  118. U.S. Department of Health and Human Services (DHHS): E-Cigarette Use among Youth and Young Adults. A Report of the Surgeon General; DHHS, Rockville, MD, USA, 2016, 275 pp. Available at: https://e-cigarettes.surgeongeneral.gov/documents/2016_SGR_Full_Report_non-508.pdf
  119. Tehrani, M.W., M.N. Newmeyer, A.M. Rule, and C. Prasse: Characterizing the Chemical Landscape in Commercial E-Cigarette Liquids and Aerosols by Liquid Chromatography-High-Resolution Mass Spectrometry; Chem. Res. Toxicol. 34 (2021) 2216–2226. DOI: 10.1021/acs.chemrestox.1c00253
  120. Mi, Y., Y. Tan, Y. Yu, D. An, R. Mo, S. Shi, and M. Li: Relationship between Smoking Status and Ulcerative Colitis: a Meta-Analysis Based on a Case–Control Study; Sci. Rep. 15 (2025) 13329. DOI: 10.1038/s41598-025-97617-9
  121. Pullan, R.D., J. Rhodes, S. Ganesh, V. Mani, J.S. Morris, G.T. Williams, R.G. Newcombe, M. Russell, C. Feyerabend, G. Thomas, and U. Sawe: Transdermal Nicotine for Active Ulcerative Colitis; N. Engl. J. Med. 330 (1994) 811–815. DOI: 10.1056/nejm199403243301202
  122. Sandborn, W.J., W.J. Tremaine, K.P. Offord, G.M. Lawson, B.T. Petersen, K.P. Batts, I.T. Croghan, L.C. Dale, D.R. Schroeder, and R.D. Hurt: Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis. A Randomized, Double-Blind, Placebo-Controlled Trial; Ann. Intern. Med. 126 (1997) 364–371. DOI: 10.7326/0003-4819-126-5-199703010-00004
  123. Sheehan, G.T., S.W. Twardus, A. Cagan, and A.N. Ananthakrishnan: E-Cigarette Use and Disease Outcomes in Inflammatory Bowel Diseases: A Case-Control Study; Dig. Dis. Sci. 68 (2023) 208–213. DOI: 10.1007/s10620-022-07539-z
  124. Parigi, T.L., O.M. Nardone, M. Lisa, L. Massimino, R. Gabbiadini, T. Innocenti, L. Bertani, A. Del Gaudio, P. Florez, L. Bertin, B. Barberio, M. Hupé, L. Lopetuso, M. Allocca, F. D'Amico, F. Furfaro, A. Zilli, G. Fiorino, F. Ungaro, F. Castiglione, et al.: The Impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study; Am. J. Gastroenterol. 121 (2025) 1954–1962. DOI: 10.14309/ajg.0000000000003810
  125. Ingram, J.R., J. Rhodes, B.K. Evans, and G.A. Thomas: Nicotine Enemas for Active Crohn's Colitis: An Open Pilot Study; Gastroenterol. Res. Pract. 2008 (2008) 237185. DOI: 10.1155/2008/237185
  126. Rosso, M. and T. Chitnis: Association between Cigarette Smoking and Multiple Sclerosis: A Review; JAMA Neurol. 77 (2020) 245–253. DOI: 10.1001/jamaneurol.2019.4271
  127. Hedström, A.K., J. Hillert, T. Olsson, and L. Alfredsson: Nicotine Might Have a Protective Effect in the Etiology of Multiple Sclerosis; Mult. Scler. 19 (2013) 1009–1013. DOI: 10.1177/1352458512471879
  128. Cleveland Clinic and Neurological Institute: Website - Smoking and MS: Unraveling the Links, Impact on Disease Progression, and Cessation Strategies; Cleveland Clinic, Cleveland, OH, USA, last updated 2026. Available at: https://my.clevelandclinic.org/departments/neurological/depts/multiple-sclerosis/ms-approaches/ms-and-smoking (accessed June 23, 2026).
  129. Hao, J., A.R. Simard, G.H. Turner, J. Wu, P. Whiteaker, R.J. Lukas, and F.D. Shi: Attenuation of CNS Inflammatory Responses by Nicotine Involves a7 and Non-a7 Nicotinic Receptors; Exp. Neurol. 227 (2011) 110–119. DOI: 10.1016/j.expneurol.2010.09.020
  130. Gao, Z., J.C. Nissen, K. Ji, and S.E. Tsirka: The Experimental Autoimmune Encephalomyelitis Disease Course Is Modulated by Nicotine and Other Cigarette Smoke Components; PLOS ONE 9 (2014) e107979. DOI: 10.1371/journal.pone.0107979
  131. Jiang, W., S. St-Pierre, P. Roy, B.J. Morley, J. Hao, and A.R. Simard: Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis; J. Immunol. 196 (2016) 2095–2108. DOI: 10.4049/jimmunol.1501613
  132. Dehara, M., N.V. Nguyen, and E.V. Arkema: Smoking and the Risk of Sarcoidosis: a Systematic Review and Meta-Analysis; Respir. Med. (2025) 108089. DOI: 10.1016/j.rmed.2025.108089
  133. Julian, M.W., G. Shao, L.S. Schlesinger, Q. Huang, D.G. Cosmar, N.Y. Bhatt, D.A. Culver, R.P. Baughman, K.L. Wood, and E.D. Crouser: Nicotine Treatment Improves Toll-Like Receptor 2 and Toll-Like Receptor 9 Responsiveness in Active Pulmonary Sarcoidosis; Chest 143 (2013) 461–470. DOI: 10.1378/chest.12-0383
  134. Crouser, E.D., R.M. Smith, D.A. Culver, M.W. Julian, K. Martin, J. Baran, C. Diaz, B.S. Erdal, and E.M. Hade: A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis; Chest 160 (2021) 1340–1349. DOI: 10.1016/j.chest.2021.05.031
  135. Tang, I.Y.K. and C.C. Mok: How the Cigarette Fire Burns the Rheumatoid Joints; JMA J. 8 (2025) 1087–1088. DOI: 10.31662/jmaj.2025-0361
  136. Ishikawa, Y. and C. Terao: The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review; Cells 9 (2020) 475. DOI: 10.3390/cells9020475
  137. Carlens, C., M.P. Hergens, J. Grunewald, A. Ekbom, A. Eklund, C.O. Hoglund, and J. Askling: Smoking, Use of Moist Snuff, and Risk of Chronic Inflammatory Diseases; Am. J. Respir. Crit. Care Med. 181 (2010) 1217–1222. DOI: 10.1164/rccm.200909-1338OC
  138. Bruchfeld, A., R.S. Goldstein, S. Chavan, N.B. Patel, M. Rosas-Ballina, N. Kohn, A.R. Qureshi, and K.J. Tracey: Whole Blood Cytokine Attenuation by Cholinergic Agonists Ex vivo and Relationship to Vagus Nerve Activity in Rheumatoid Arthritis; J. Intern. Med. 268 (2010) 94–101. DOI: 10.1111/j.1365-2796.2010.02226.x
  139. Esbensen, B.A., T. Thomsen, I.K. Roelsgaard, M. Østergaard, M.L. Hetland, L. Andersen, H. Tønnesen, A.G. Semb, and R. Christensen: Effect of an Intensive Smoking Cessation Intervention on Smoking Cessation and Disease Activity in Patients with RA: a Randomized Controlled Trial; Rheumatology 65 (2026). DOI: 10.1093/rheumatology/keaf448
  140. Cleveland Clinic: Website - Sepsis; Cleveland Clinic, Cleveland, OH, USA, last updated February 18, 2026. Available at: https://my.clevelandclinic.org/health/diseases/12361-sepsis (accessed June 23, 2026).
  141. Lee, E.H., K.H. Lee, K.-n. Lee, Y. Park, K. Do Han, and S.H. Han: The Relation between Cigarette Smoking and Development of Sepsis: A 10-Year Follow-up Study of Four Million Adults from the National Health Screening Program; J. Epidemiol. Glob. Health 14 (2024) 444–452. DOI: 10.1007/s44197-024-00197-6
  142. Özdemir-Kumral, Z.N., D. Özbeyli, A.F. Özdemir, B.M. Karaaslan, K. Kaytaz, M.F. Kara, O.E. Tok, F. Ercan, and B.C. Yeğen: Protective Effect of Nicotine on Sepsis-Induced Oxidative Multiorgan Damage: Role of Neutrophils; Nicotine Tob. Res. 19 (2017) 859–864. DOI: 10.1093/ntr/ntw198
  143. Wang, H., H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E.J. Miller, K.J. Tracey, and L. Ulloa: Cholinergic Agonists Inhibit Hmgb1 Release and Improve Survival in Experimental Sepsis; Nat. Med. 10 (2004) 1216–1221. DOI: 10.1038/nm1124
  144. Keever, K.R., K. Cui, J.L. Casteel, S. Singh, D.B. Hoover, D.L. Williams, V.A. Pavlov, and V.P. Yakubenko: Cholinergic signaling via the α7 Nicotinic Acetylcholine Receptor regulates the Migration of Monocyte-Derived Macrophages during Acute Inflammation; J. Neuroinflamm. 21 (2024) 3. DOI: 10.1186/s12974-023-03001-7
  145. Thomas, G.A., J. Rhodes, V. Mani, G.T. Williams, R.G. Newcombe, M.A. Russell, and C. Feyerabend: Transdermal Nicotine as Maintenance Therapy for Ulcerative Colitis; N. Engl. J. Med. 332 (1995) 988–992. DOI: 10.1056/NEJM199504133321503
  146. Thomas, G.A., J. Rhodes, K. Ragunath, V. Mani, G.T. Williams, R.G. Newcombe, M.A. Russell, and C. Feyerabend: Transdermal Nicotine Compared with Oral Prednisolone Therapy for Active Ulcerative Colitis; Eur. J. Gastroenterol. Hepatol. 8 (1996) 769–776.
  147. McGrath, J., J.W. McDonald, and J.K. Macdonald: Transdermal Nicotine for Induction of Remission in Ulcerative Colitis; Cochrane Database Syst. Rev. (2004) CD004722. DOI: 10.1002/14651858.CD004722.pub2
  148. Mayo Clinic: Website - Ulcerative Colitis; Mayo Clinic, last updated June 6, 2026. Available at: https://www.mayoclinic.org/diseases-conditions/ulcerative-colitis/diagnosis-treatment/drc-20353331#:~:text=Types%20of%20biologics%20used%20to,produced%20by%20the%20immune%20system (accessed June 23, 2026).
  149. Briggs, F.B.: Nicotinic Acetylcholine Receptors α7 and α9 Modifies Tobacco Smoke Risk for Multiple Sclerosis; Mult. Scler. J. 27 (2021) 1166–1174. DOI: 10.1177/1352458520958361
  150. Khezri, S., S.M. Abtahi Froushani, and M. Shahmoradi: Nicotine Augments the Beneficial Effects of Mesenchymal Stem Cell-Based Therapy in Rat Model of Multiple Sclerosis; Immunol. Invest. 47 (2018) 113–124. DOI: 10.1080/08820139.2017.1391841
  151. Rothbard, J.B., M.P. Kurnellas, S.S. Ousman, S. Brownell, J.J. Rothbard, and L. Steinman: Small Heat Shock Proteins, Amyloid Fibrils, and Nicotine Stimulate a Common Immune Suppressive Pathway with Implications for Future Therapies; Cold Spring Harb. Perspect. Med. 9 (2019) a034223. DOI: 10.1101/cshperspect.a034223
  152. Xiao, X., T. Cui, S. Hu, S. Shen, Y. Huang, C. Cui, H. Tan, W. Qiu, and Y. Zhao: Mechanistic Insights into Nicotine-Derived Nitrosamine Ketone (NNK) in Multiple Sclerosis via Integrated Systems Analyses; Gene 997 (2026) 150158. DOI: 10.1016/j.gene.2026.150158
  153. Richmond, R.C. and G. Davey Smith: Mendelian Randomization: Concepts and Scope; Cold Spring Harb. Perspect. Med. 12 (2022) a040501. DOI: 10.1101/cshperspect.a040501
  154. Huang, J., X. Liu, Y. Wei, X. Li, S. Gao, L. Dong, X. Rao, and J. Zhong: Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease; Front. Immunol. 13 (2022) 830863. DOI: 10.3389/fimmu.2022.830863
  155. Belperio, J.A., M.C. Fishbein, F. Abtin, J. Channick, S.A. Balasubramanian, and J.P. Lynch III: Pulmonary Sarcoidosis: A Comprehensive Review: Past to Present; J. Autoimmun. 149 (2024) 103107. DOI: 10.1016/j.jaut.2023.103107
  156. Arkema, E.V. and Y.C. Cozier: Sarcoidosis Epidemiology: Recent Estimates of Incidence, Prevalence and Risk Factors; Curr. Opin. Pulm. Med. 26 (2020) 527–534. DOI: 10.1097/mcp.0000000000000715
  157. Rossides, M., P. Darlington, S. Kullberg, and E.V. Arkema: Sarcoidosis: Epidemiology and Clinical Insights; J. Intern. Med. 293 (2023) 668–680. DOI: 10.1111/joim.13629
  158. Isaji, H. and K. Yamada: A Survey on the Actual Use of and Reasons for Heated Tobacco Products in Patients with Rheumatoid Arthritis; Int. J. Environ. Res. Public Health 19 (2022) 12465. DOI: 10.3390/ijerph191912465
  159. Lee, J., A. Luria, C. Rhodes, H. Raghu, N. Lingampalli, O. Sharpe, B. Rada, D.H. Sohn, W.H. Robinson, and J. Sokolove: Nicotine Drives Neutrophil Extracellular Traps Formation and Accelerates Collagen-Induced Arthritis; Rheumatology 56 (2017) 644–653. DOI: 10.1093/rheumatology/kew449
  160. van Maanen, M.A., M.C. Lebre, T. van der Poll, G.J. LaRosa, D. Elbaum, M.J. Vervoordeldonk, and P.P. Tak: Stimulation of Nicotinic Acetylcholine Receptors Attenuates Collagen-Induced Arthritis in Mice; Arthritis Rheum. 60 (2009) 114–122. DOI: 10.1002/art.24177
  161. Yu, H., Y.-H. Yang, R. Rajaiah, and K.D. Moudgil: Nicotine-Induced Differential Modulation of Autoimmune Arthritis in the Lewis Rat Involves Changes in Interleukin-17 and Anti–Cyclic Citrullinated Peptide Antibodies; Arthritis Rheum. 63 (2011) 981–991. DOI: 10.1002/art.30219
  162. Wasén, C., M. Turkkila, A. Bossios, M. Erlandsson, K.M. Andersson, L. Ekerljung, C. Malmhäll, M. Brisslert, S. Töyrä Silfverswärd, B. Lundbäck, and M.I. Bokarewa: Smoking Activates Cytotoxic Cd8+ T Cells and Causes Survivin Release in Rheumatoid Arthritis; J. Autoimmun. 78 (2017) 101–110. DOI: 10.1016/j.jaut.2016.12.009
  163. Chiou, S.K., M.K. Jones, and A.S. Tarnawski: Survivin - an Anti-Apoptosis Protein: Its Biological Roles and Implications for Cancer and Beyond; Med. Sci. Monit. 9 (2003) PI43–PI47.
  164. Hashimoto, M., S.S. Ramalingam, and R. Ahmed: Harnessing Cd8 T Cell Responses Using PD-1–IL-2 Combination Therapy; Trends Cancer 10 (2024) 332–346. DOI: 10.1016/j.trecan.2023.11.008
  165. Lourido, L., V. Calamia, P. Fernández-Puente, J. Mateos, N. Oreiro, F.J. Blanco, and C. Ruiz-Romero: Secretome Analysis of Human Articular Chondrocytes Unravels Catabolic Effects of Nicotine on the Joint; Proteomics Clin. Appl. 10 (2016) 671–680. DOI: 10.1002/prca.201400186
  166. Wu, W. and J. Krijgsveld: Secretome Analysis: Reading Cellular Sign Language to Understand Intercellular Communication; Mol. Cell. Proteomics 23 (2024) 100692. DOI: 10.1016/j.mcpro.2023.100692
  167. Recklies, A.D., H. Ling, C. White, and S.M. Bernier: Inflammatory Cytokines Induce Production of Chi3l1 by Articular Chondrocytes; J. Biol. Chem. 280 (2005) 41213–41221. DOI: 10.1074/jbc.M510146200
  168. World Health Organization (WHO): Website - International Statistical Classification of Diseases and Related Health Problems (Icd) - ICD-10 Version:2016; WHO, Geneva, Switzerland, Available at: https://icd.who.int/browse10/2016/en (accessed August 13, 2026).
  169. Lawand, J., A. Ghali, J. Hauck, S. Trejo Corona, R. Gonzalez, and L. Deveza: The Smokeless Paradox: Nontobacco Nicotine Use and Complications in Anterior Cervical Discectomy and Fusion; J. Am. Acad. Orthop. Surg. 33 (2024) 1032–1039. DOI: 10.5435/JAAOS-D-24-00801
  170. Fuller, Z., A. Chopra, J. Thomas, D. Oliver, M. Fisher, and Z.E. Abdo: Increased Postoperative Complications in Non-Tobacco Nicotine Users Following Total Hip Arthroplasty; J. Arthroplasty 41 (2026) 2113–2118 e2111. DOI: 10.1016/j.arth.2025.10.032
  171. Good, L.M., C.W. Blackburn, J.M. Adelstein, A.N. Berk, S.A. Florentino, H.S. Jawanda, and W.B. Cohen-Levy: What Is the Association between Nontobacco Nicotine Dependence and Postoperative Complications in Total Hip Arthroplasty? A Large Propensity-Matched Cohort Study; Arthroplast. Today 34 (2025) 101743. DOI: 10.1016/j.artd.2025.101743
  172. Hirpara, A., A. Shah, A.J. Moyal, J.M. Adelstein, R.J. Burkhart, C. Stirpe, C.W. Cheng, Z.L. Gordon, C.G. Furey, and P.V. Rajan: Impact of Non-Tobacco Nicotine Dependence on Outcomes Following Anterior Lumbar Interbody Fusion; Spine (2025) DOI: 10.1097/brs.0000000000005555
  173. Lawand, J., A. Ghali, A.-H. Dajani, P. Boufadel, H. Bey, A. Khan, and J. Abboud: Nontobacco Nicotine Dependence and Rates of Periprosthetic Joint Infection and Other Postoperative Complications in Shoulder Arthroplasty: A Retrospective Analysis; J. Am. Acad. Orthop. Surg. 33 (2025) 92–99. DOI: 10.5435/jaaos-d-24-00706
  174. Spitzer, C., M. Romoff, M. Brunette, M.K. Peterson, A. Ton, R. Le, A. Sharma, J.P. Chan, H.-H. Wu, S. Hashmi, and M.S. Kim: Non-Tobacco Nicotine Dependence Increases Risk of Complications Following Lumbar Spine Decompression and Fusion; N. Am. Spine Soc. J. 24 (2025) 100790. DOI: 10.1016/j.xnsj.2025.100790
  175. Glenn, E.R., A.R. Zhu, E. Mao, A. Astavans, I.R. Beeram, and U. Srikumaran: Nontobacco Nicotine Dependence as a Risk Factor for Poor Long-Term Outcomes after Shoulder Arthroplasty and Rotator Cuff Repair; J. Am. Acad. Orthop. Surg. Glob. Res. Rev. 10 (2026) e25.00035. DOI: 10.5435/JAAOSGlobal-D-25-00035
  176. Lawand, J.J., A. Ghali, J.T. Morrow, D. Birhiray, Y.M. Khalafallah, and L. Deveza: Non-Tobacco Nicotine Dependence and Incidence of Pseudarthrosis and Other Postoperative Complications in Lumbar Fusion Surgery: a Retrospective Analysis; Eur. J. Orthop. Surg. Traumatol. 36 (2026) 137. DOI: 10.1007/s00590-026-04714-0
  177. McCahon, J.A.S., S. Fehr, G.M. Thomas, J.N. Daniel, D.I. Pedowitz, and S.G. Parekh: Non-Tobacco Nicotine Dependence and Postoperative Complications after Total Ankle Arthroplasty: A Propensity-Matched Cohort Study; Food Ankle Surg. (2026). DOI: 10.1016/j.fas.2026.04.006
  178. Wang, J., A. Patel, P. Nguyen, M. Panchbhavi, and V.K. Panchbhavi: Postoperative Complications after Hammertoe Correction: The Influence of Tobacco and Non-Tobacco Nicotine; J. Foot Ankle Surg. 65 (2026) 33.e31–33.e35. DOI: 10.1053/j.jfas.2025.09.007
  179. Corriden, R., A. Moshensky, C.M. Bojanowski, A. Meier, J. Chien, R.K. Nelson, and L.E. Crotty Alexander: E-Cigarette Use Increases Susceptibility to Bacterial Infection by Impairment of Human Neutrophil Chemotaxis, Phagocytosis, and Net Formation; Am. J. Physiol. Cell Physiol. 318 (2020) C205–C214. DOI: 10.1152/ajpcell.00045.2019
  180. Zuck, K.: Evidence Related to the Health Risk of IQOS Use; presented at the TPSAC Meeting, Evaluation of Product Chemistry, January 24–25, 2018.
  181. Fried, N.D. and J.D. Gardner: Heat-Not-Burn Tobacco Products: An Emerging Threat to Cardiovascular Health; Am. J. Physiol. Heart Circ. Physiol. 319 (2020) H1234–H1239. DOI: 10.1152/ajpheart.00708.2020
  182. R.J. Reynolds Tobacco Company: Chemical and Biological Studies on New Cigarette Prototypes That Heat Instead of Burn Tobacco; 1988, XXV, 744 S. pp. Available at: https://www.industrydocuments.ucsf.edu/tobacco/documents/viewer/?iid=ltnb0140&id=ltnb0140&q=null%2Cbates%2Ccontains%2C570247258&db-set=documents&industry=tobacco&sort=relevance&pg=1&npp=20&rtool=metadata (accessed June 23, 2026).
  183. Schaller, J.-P., D. Keller, L. Poget, P. Pratte, E. Kaelin, D. McHugh, G. Cudazzo, D. Smart, A.R. Tricker, L. Gautier, M. Yerly, R. Reis Pires, S. Le Bouhellec, D. Ghosh, I. Hofer, E. Garcia, P. Vanscheeuwijck, and S. Maeder: Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical Composition, Genotoxicity, Cytotoxicity, and Physical Properties of the Aerosol; Regul. Toxicol. Pharmacol. 81 Suppl 2 (2016) S27–S47. DOI: 10.1016/j.yrtph.2016.10.001
  184. Cozzani, V., F. Barontini, T. McGrath, B. Mahler, M. Nordlund, M. Smith, J.P. Schaller, and G. Zuber: An Experimental Investigation into the Operation of an Electrically Heated Tobacco System; Thermochim. Acta 684 (2020) 178475. DOI: 10.1016/j.tca.2019.178475
  185. Rennard, S.I., T. Umino, T. Millatmal, D.M. Daughton, L.S. Manouilova, F.A. Ullrich, K.D. Patil, D.J. Romberger, A.A. Floreani, and J.R. Anderson: Evaluation of Subclinical Respiratory Tract Inflammation in Heavy Smokers Who Switch to a Cigarette-Like Nicotine Delivery Device That Primarily Heats Tobacco; Nicotine Tob. Res. 4 (2002) 467–476. DOI: 10.1080/1462220021000018407
  186. Caponnetto, P., D. Campagna, G. Papale, C. Russo, and R. Polosa: The Emerging Phenomenon of Electronic Cigarettes; Expert Rev. Respir. Med. 6 (2012) 63–74. DOI: 10.1586/ers.11.92
  187. Shen, X., M. Hindle, and P.R. Byron: Effect of Energy on Propylene Glycol Aerosols Using the Capillary Aerosol Generator; Int. J. Pharm. 275 (2004) 249–258. DOI: 10.1016/j.ijpharm.2004.02.005
  188. Weaver, M., A. Breland, T. Spindle, and T. Eissenberg: Electronic Cigarettes: a Review of Safety and Clinical Issues; J. Addict. Med. 8 (2014) 234–240. DOI: 10.1097/ADM.0000000000000043
  189. Jaegers, N.R., W. Hu, T.J. Weber, and J.Z. Hu: Low-Temperature (< 200 °C) Degradation of Electronic Nicotine Delivery System Liquids Generates Toxic Aldehydes; Sci. Rep. 11 (2021) 7800. DOI: 10.1038/s41598-021-87044-x
  190. Oh, A.Y. and A. Kacker: Do Electronic Cigarettes Impart a Lower Potential Disease Burden Than Conventional Tobacco Cigarettes?: Review on E-Cigarette Vapor Versus Tobacco Smoke; Laryngoscope 124 (2014) 2702–2706. DOI: 10.1002/lary.24750
  191. Saliba, N.A., A. El Hellani, E. Honein, R. Salman, S. Talih, J. Zeaiter, and A. Shihadeh: Surface Chemistry of Electronic Cigarette Electrical Heating Coils: Effects of Metal Type on Propylene Glycol Thermal Decomposition; J. Anal. Appl. Pyrolysis 134 (2018) 520–525. DOI: 10.1016/j.jaap.2018.07.019
  192. AlGemayel, C., E. Honein, A.E. Hellani, R. Salman, N.A. Saliba, A. Shihadeh, and J. Zeaiter: Kinetic Modeling of the Pyrolysis of Propylene Glycol; Eng. Sci. 20 (2022) 162–179. DOI: 10.30919/es8d757
  193. BenchChem Technical Support Team: The Thermal Decomposition of Propylene Glycol: A Comprehensive Technical Guide; BenchChem, Ontario, CA, USA, 2026, Available at: https://www.benchchem.com/product/b7767615/docs#the-thermal-decomposition-ofpropylene-glycol-a-comprehensive-technical-guide (accessed June 23, 2026).
  194. Pinto, M.I., J. Thissen, N. Hermes, A. Cunningham, H. Digard, and J. Murphy: Chemical Characterisation of the Vapour Emitted by an E-Cigarette Using a Ceramic Wick-Based Technology; Sci. Rep. 12 (2022) 16497. DOI: 10.1038/s41598-022-19761-w
  195. David, G., E.A. Parmentier, I. Taurino, and R. Signorell: Tracing the Composition of Single E-Cigarette Aerosol Droplets in situ by Laser-Trapping and Raman Scattering; Sci. Rep. 10 (2020) 7929. DOI: 10.1038/s41598-020-64886-5
  196. Orellana-Barrios, M.A., D. Payne, Z. Mulkey, and K. Nugent: Electronic Cigarettes—A Narrative Review for Clinicians; Am. J. Med. 128 (2015) 674–681. DOI: 10.1016/j.amjmed.2015.01.033
  197. Yayan, J., K.J. Franke, C. Biancosino, and K. Rasche: Comparative Systematic Review on the Safety of E-Cigarettes and Conventional Cigarettes; Food Chem. Toxicol. 185 (2024) 114507. DOI: 10.1016/j.fct.2024.114507
  198. Balfour, D.J.K., N.L. Benowitz, S.M. Colby, D.K. Hatsukami, H.A. Lando, S.J. Leischow, C. Lerman, R.J. Mermelstein, R. Niaura, K.A. Perkins, O.F. Pomerleau, N.A. Rigotti, G.E. Swan, K.E. Warner, and R. West: Balancing Consideration of the Risks and Benefits of E-Cigarettes; Am. J. Public Health 111 (2021) 1661–1672. DOI: 10.2105/ajph.2021.306416
  199. U.S. Food & Drug Administration (FDA): Website - FDA Makes Determinations On More Than 99% of the 26 Million Tobacco Products for Which Applications Were Submitted; FDA, Silver Spring, MD, USA, last updated March 15, 2023. Available at: https://www.fda.gov/tobacco-products/ctp-newsroom/fda-makes-determinations-more-99-26-million-tobacco-products-which-applications-were-submitted#:~:text=To%20date%2C%20FDA%20has%20made%20determinations%20on,deemed%20products%20for%20which%20applications%20were%20submitted (accessed June 23, 2026).
  200. U.S. Food & Drug Administration (FDA): Website - Advisory and Enforcement Actions against Industry for Unauthorized Tobacco Products; FDA, Silver Spring, MD, USA, last updated May 18, 2026. Available at: https://www.fda.gov/tobacco-products/compliance-enforcement-training/advisory-and-enforcement-actions-against-industry-unauthorized-tobacco-products#:~:text=On%20December%2019%2C%202024%2C%20FDA,is%20subject%20to%20enforcement%20action (accessed June 23, 2026).
  201. U.S. Department of Health and Human Services (DHHS), U.S. Food & Drug Administration (FDA), and Center for Tobacco Products (CTP): Website - FDA Deems Certain Tobacco Products Subject to FDA Authority, Sales and Distribution Restrictions, and Health Warning Requirements for Packages and Advertisements – Guidance for Industry, Small Entity Compliance Guide; FDA, Silver Spring, MD, USA, last updated March 17, 2023. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-deems-certain-tobacco-products-subject-fda-authority-sales-and-distribution-restrictions-and (accessed June 23, 2026).
  202. U.S. Food & Drug Administration (FDA): Website - Want to Quit Smoking? FDA-Approved and FDA-Cleared Cessation Products Can Help; FDA, Silver Spring, MD, USA, last updated July 21, 2022. Available at: https://www.fda.gov/consumers/consumer-updates/want-quit-smoking-fda-approved-and-fda-cleared-cessation-products-can-help (accessed June 23, 2026).
  203. Rigotti, N.A.: Electronic Cigarettes for Smoking Cessation — Have We Reached a Tipping Point?; N. Engl. J. Med. 390 (2024) 664–665. DOI: 10.1056/NEJMe2314977
  204. Nichols, M. and E. Rivera: Website - Faa Issues Final Mosaic Rule: Key Updates and Changes – Major Modernizations for Light-Sport Aircraft Certification, Operation, and Privileges; DLA Piper US, last updated July 25, 2025. Available at: https://www.dlapiper.com/en-us/insights/publications/2025/07/faa-issues-final-mosaic-rule (accessed June 23, 2026).
  205. U.S. Department of Health and Human Services (DHHS) and Centers for Disease Control and Prevention (CDC): E-Cigarette, or Vaping, Products Visual Dictionary; CDC, 2019, 25 pp. Available at: https://stacks.cdc.gov/view/cdc/103783/cdc_103783_DS1.pdf (accessed June 23, 2026).
  206. Meebaco: Website - MBC0018 DTL Device | Replaceable Pods, 15w/25w Modes & Dynamic Screen; Available at: https://www.meebaco.com/products/mbc0018.html (accessed July 12, 2026).
  207. Jackson, R.: Website - What Wattage Should I Vape At?; OK Vape, Exeter, UK, last updated May 6, 2026. Available at: https://okvape.co.uk/blog/vaping-beginners/what-wattage-should-i-vape-at/?srsltid=AfmBOopTBC2CqiHrBLWztBqgb8aedKdPZxYs35wpXEsQ_oPtS80Z_Oki (accessed June 23, 2026).
  208. Li, Y., A.E. Burns, L.N. Tran, K.A. Abellar, M. Poindexter, X. Li, A.K. Madl, K.E. Pinkerton, and T.B. Nguyen: Impact of E-Liquid Composition, Coil Temperature, and Puff Topography on the Aerosol Chemistry of Electronic Cigarettes; Chem. Res. Toxicol. 34 (2021) 1640–1654. DOI: 10.1021/acs.chemrestox.1c00070
  209. Tran, L.N., E.Y. Chiu, H.C. Hunsaker, K.-C. Wu, B.A. Poulin, A.K. Madl, K.E. Pinkerton, and T.B. Nguyen: Carbonyls and Aerosol Mass Generation from Vaping Nicotine Salt Solutions Using Fourth- and Third-Generation E-Cigarette Devices: Effects of Coil Resistance, Coil Age, and Coil Metal Material; Chem. Res. Toxicol. 36 (2023) 1599–1610. DOI: 10.1021/acs.chemrestox.3c00172
  210. Zhao, J., G. Pyrgiotakis, and P. Demokritou: Development and Characterization of Electronic-Cigarette Exposure Generation System (Ecig-EGS) for the Physico-Chemical and Toxicological Assessment of Electronic Cigarette Emissions; Inhal. Toxicol. 28 (2016) 658–669. DOI: 10.1080/08958378.2016.1246628
  211. Lalo, H., L. Leclerc, J. Sorin, and J. Pourchez: Aerosol Droplet-Size Distribution and Airborne Nicotine Portioning in Particle and Gas Phases Emitted by Electronic Cigarettes; Sci. Rep. 10 (2020) 21707. DOI: 10.1038/s41598-020-78749-6
  212. Salazar, M.R., L. Saini, T.B. Nguyen, K.E. Pinkerton, A.K. Madl, A.M. Cole, and B.A. Poulin: Elevated Toxic Element Emissions from Popular Disposable E-Cigarettes: Sources, Life Cycle, and Health Risks; ACS Cent. Sci. 11 (2025) 1345–1354. DOI: 10.1021/acscentsci.5c00641
  213. Aherrera, A., J.J. Lin, R. Chen, M. Tehrani, A. Schultze, A. Borole, S. Tanda, W. Goessler, and A.M. Rule: Metal Concentrations in E-Cigarette Aerosol Samples: A Comparison by Device Type and Flavor; Environ. Health Perspect. 131 (2023) 127004. DOI: 10.1289/ehp11921
  214. AlGemayel, C., R. Salman, N.A. Saliba, A. Shihadeh, and J. Zeaiter: An Experimental Investigation of PG/VG Pyrolysis Combined with Molecular Dynamics; J. Anal. Appl. Pyrolysis 179 (2024) 106483. DOI: 10.1016/j.jaap.2024.106483
  215. Hikisz, P. and D. Jacenik: The Tobacco Smoke Component, Acrolein, as a Major Culprit in Lung Diseases and Respiratory Cancers: Molecular Mechanisms of Acrolein Cytotoxic Activity; Cells 12 (2023) 879. DOI: 10.3390/cells12060879
  216. Bhat, A.A., M. Afzal, A. Goyal, G. Gupta, R. Thapa, W.H. almalki, I. Kazmi, S.I. Alzarea, M. Shahwan, K.R. Paudel, H. Ali, D. Sahu, P. Prasher, S.K. Singh, and K. Dua: The Impact of Formaldehyde Exposure on Lung Inflammatory Disorders: Insights into Asthma, Bronchitis, and Pulmonary Fibrosis; Chem. Biol. Interact. 394 (2024) 111002. DOI: 10.1016/j.cbi.2024.111002
  217. Matsuse, H., C. Fukushima, T. Shimoda, S. Asai, and S. Kohno: Effects of Acetaldehyde on Human Airway Constriction and Inflammation; in: Acetaldehyde-Related Pathology: Bridging the Trans-Disciplinary Divide, 2006, pp. 97–109. DOI: 10.1002/9780470511848.ch7
  218. Kawano, T., H. Matsuse, S. Fukahori, T. Tsuchida, T. Nishino, C. Fukushima, and S. Kohno: Acetaldehyde at a Low Concentration Syner-gistically Exacerbates Allergic Airway Inflammation as an Endocrine-Disrupting Chemical and as a Volatile Organic Compound; Respiration 84 (2012) 135–141. DOI: 10.1159/000337112
  219. National Research Council: Acetaldehyde; in: Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants: Volume 3, The National Academies Press, Washington, DC, USA, ISBN: 0309143799, 2009, pp. 20–45. DOI: 10.17226/12741
  220. Simovic, T., C. Matheson, A. Rodgers, F. Baig, A. Breland, C. Cobb O, P. Nana-Sinkam, and P. Rodriguez-Miguelez: Immune Cell Profile in Young Adults Who Regularly Use E-Cigarettes and the Role of Nicotine; Physiology 39 (2024) 1591. DOI: 10.1152/physiol.2024.39.S1.1591
  221. Chatterjee, S., J.Q. Tao, A. Johncola, W. Guo, A. Caporale, M.C. Langham, and F.W. Wehrli: Acute Exposure to E-Cigarettes Causes Inflammation and Pulmonary Endothelial Oxidative Stress in Nonsmoking, Healthy Young Subjects; Am. J. Physiol. Lung Cell. Mol. Physiol. 317 (2019) L155–L166. DOI: 10.1152/ajplung.00110.2019
  222. Chatterjee, S., A. Caporale, J.Q. Tao, W. Guo, A. Johncola, A.A. Strasser, F.T. Leone, M.C. Langham, and F.W. Wehrli: Acute E-Cig Inhalation Impacts Vascular Health: a Study in Smoking Naïve Subjects; Am. J. Physiol. Heart Circ. Physiol. 320 (2021) H144–H158. DOI: 10.1152/ajpheart.00628.2020
  223. Andreozzi, P., G. Gussoni, G. Sesti, N. Montano, A. Pietrangelo, S. Basili, C. Bracco, A. Cittadini, G. Desideri, G. Mancuso, M. Persico, S. Petrolani, M. Pirisi, L.A. Sechi, P. Suppressa, A. Vacca, V. Zaccone, and G. the Italian Society of Internal Medicine Council Member: Impact of Electronic Cigarettes (E-Cigs) and Heat-Not-Burn/Heated Tobacco Products (HnB/HTP) on Asthma and Chronic Obstructive Pulmonary Disease: A Viewpoint of the Italian Society of Internal Medicine; Intern. Emerg. Med. 19 (2024) 1829–1837. DOI: 10.1007/s11739-024-03648-x
  224. Coppeta, L., A. Magrini, A. Pietroiusti, S. Perrone, and M. Grana: Effects of Smoking Electronic Cigarettes on Pulmonary Function and Environmental Parameters; Open Public Health J. 11 (2018) 360–368. DOI: 10.2174/1874944501811010360
  225. Ghosh, A., R.C. Coakley, T. Mascenik, T.R. Rowell, E.S. Davis, K. Rogers, M.J. Webster, H. Dang, L.E. Herring, M.F. Sassano, A. Livraghi-Butrico, S.K. Van Buren, L.M. Graves, M.A. Herman, S.H. Randell, N.E. Alexis, and R. Tarran: Chronic E-Cigarette Exposure Alters the Human Bronchial Epithelial Proteome; Am. J. Respir. Crit. Care Med. 198 (2018) 67–76. DOI: 10.1164/rccm.201710-2033OC
  226. Ghosh, A., R.D. Coakley, A.J. Ghio, M.S. Muhlebach, C.R. Esther, N.E. Alexis, and R. Tarran: Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung; Am. J. Respir. Crit. Care Med. 200 (2019) 1392–1401. DOI: 10.1164/rccm.201903-0615OC
  227. Hernandez, M.L., A.J. Burbank, N.E. Alexis, M.E. Rebuli, E.D. Hickman, I. Jaspers, and G. Guidos: Electronic Cigarettes and Their Impact on Allergic Respiratory Diseases: A Work Group Report of the AAAAI Environmental Exposures and Respiratory Health Committee; J. Allergy Clin. Immunol. Pract. 9 (2021) 1142–1151. DOI: 10.1016/j.jaip.2020.12.065
  228. Kim, T. and J. Kang: Association between Dual Use of E-Cigarette and Cigarette and Chronic Obstructive Pulmonary Disease: An Analysis of a Nationwide Representative Sample from 2013 to 2018; BMC Pulm. Med. 21 (2021) 231. DOI: 10.1186/s12890-021-01590-8
  229. Kotoulas, S.C., A. Pataka, K. Domvri, D. Spyratos, P. Katsaounou, K. Porpodis, E. Fouka, A. Markopoulou, K. Passa-Fekete, I. Grigoriou, T. Kontakiotis, P. Argyropoulou, and D. Papakosta: Acute Effects of E-Cigarette Vaping on Pulmonary Function and Airway Inflammation in Healthy Individuals and in Patients with Asthma; Respirology 25 (2020) 1037–1045. DOI: 10.1111/resp.13806
  230. Lappas, A.S., A.S. Tzortzi, E.M. Konstantinidi, S.I. Teloniatis, C.K. Tzavara, S.A. Gennimata, N.G. Koulouris, and P.K. Behrakis: Short-Term Respiratory Effects of E-Cigarettes in Healthy Individuals and Smokers with Asthma; Respirology 23 (2018) 291–297. DOI: 10.1111/resp.13180
  231. McConnell, R., J.L. Barrington-Trimis, K. Wang, R. Urman, H. Hong, J. Unger, J. Samet, A. Leventhal, and K. Berhane: Electronic Cigarette Use and Respiratory Symptoms in Adolescents; Am. J. Respir. Crit. Care Med. 195 (2017) 1043–1049. DOI: 10.1164/rccm.201604-0804OC
  232. Meo, S.A., M.A. Ansary, F.R. Barayan, A.S. Almusallam, A.M. Almehaid, N.S. Alarifi, T.A. Alsohaibani, and I. Zia: Electronic Cigarettes: Impact on Lung Function and Fractional Exhaled Nitric Oxide among Healthy Adults; Am. J. Mens. Health 13 (2019) 1557988318806073. DOI: 10.1177/1557988318806073
  233. Reidel, B., G. Radicioni, P.W. Clapp, A.A. Ford, S. Abdelwahab, M.E. Rebuli, P. Haridass, N.E. Alexis, I. Jaspers, and M. Kesimer: E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion; Am. J. Respir. Crit. Care Med. 197 (2018) 492–501. DOI: 10.1164/rccm.201708-1590OC
  234. Shields, P.G., M.-A. Song, J.L. Freudenheim, T.M. Brasky, J.P. McElroy, S.A. Reisinger, D.Y. Weng, R. Ren, T. Eissenberg, M.D. Wewers, and K. Shilo: Lipid Laden Macrophages and Electronic Cigarettes in Healthy Adults; EBioMedicine 60 (2020) 102982. DOI: 10.1016/j.ebiom.2020.102982
  235. Singh, K.P., G. Lawyer, T. Muthumalage, K.P. Maremanda, N.A. Khan, S.R. McDonough, D. Ye, S. McIntosh, and I. Rahman: Systemic Biomarkers in Electronic Cigarette Users: Implications for Noninvasive Assessment of Vaping-Associated Pulmonary Injuries; ERJ Open Res. 5 (2019) 00182–02019. DOI: 10.1183/23120541.00182-2019
  236. Song, M.A., J.L. Freudenheim, T.M. Brasky, E.A. Mathe, J.P. McElroy, Q.A. Nickerson, S.A. Reisinger, D.J. Smiraglia, D.Y. Weng, K.L. Ying, M.D. Wewers, and P.G. Shields: Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users; Cancer Epidemiol. Biomarkers Prev. 29 (2020) 443–451. DOI: 10.1158/1055-9965.Epi-19-1245
  237. Song, M.A., S.A. Reisinger, J.L. Freudenheim, T.M. Brasky, E.A. Mathé, J.P. McElroy, Q.A. Nickerson, D.Y. Weng, M.D. Wewers, and P.G. Shields: Effects of Electronic Cigarette Constituents on the Human Lung: A Pilot Clinical Trial; Cancer Prev. Res. 13 (2020) 145–152. DOI: 10.1158/1940-6207.Capr-19-0400
  238. Kim, T., Y. Kim, and J. Kang: Association of Electronic Cigarette Exposure with Serum Uric Acid Level and Hyperuricemia: 2016–2017 Korea National Health and Nutritional Examination Survey; PLOS ONE 16 (2021) e0247868. DOI: 10.1371/journal.pone.0247868
  239. Xie, Z., D.J. Ossip, I. Rahman, and D. Li: Use of Electronic Cigarettes and Self-Reported Chronic Obstructive Pulmonary Disease Diagnosis in Adults; Nicotine Tob. Res. 22 (2020) 1155–1161. DOI: 10.1093/ntr/ntz234
  240. Amraotkar, A.R., U.S. Owolabi, M.V. Malovichko, S. Majid, R.M. Weisbrod, E.J. Benjamin, J.L. Fetterman, G.A. Hirsch, S. Srivastava, R. Poudel, R.M. Robertson, A. Bhatnagar, N.M. Hamburg, and R.J. Keith: Association of Electronic Cigarette Use with Circulating Angiogenic Cell Levels in Healthy Young Adults: Evidence for Chronic Systemic Injury; Vasc. Med. 28 (2023) 18–27. DOI: 10.1177/1358863x221126205
  241. Benowitz, N.L., G. St.Helen, N. Nardone, N. Addo, J. Zhang, A.M. Harvanko, C.S. Calfee, and P. Jacob III: Twenty-Four-Hour Cardiovascular Effects of Electronic Cigarettes Compared with Cigarette Smoking in Dual Users; J. Am. Heart Assoc. 9 (2020) e017317. DOI: 10.1161/JAHA.120.017317
  242. Boakye, E., S.M.I. Uddin, N. Osuji, J. Meinert, O.H. Obisesan, M. Mirbolouk, E. Tasdighi, O. El-Shahawy, J. Erhabor, A.D. Osei, T. Rajan, M. Patatanian, J.T. Holbrook, A. Bhatnagar, S.S. Biswal, and M.J. Blaha: Examining the Association of Habitual E-Cigarette Use with Inflammation and Endothelial Dysfunction in Young Adults: The Vapors-Endothelial Function Study; Tob. Induc. Dis. 21 (2023) 75. DOI: 10.18332/tid/162327
  243. Chaumont, M., B. de Becker, W. Zaher, A. Culié, G. Deprez, C. Mélot, F. Reyé, P. Van Antwerpen, C. Delporte, N. Debbas, K.Z. Boudjeltia, and P. van de Borne: Differential Effects of E-Cigarette on Microvascular Endothelial Function, Arterial Stiffness and Oxidative Stress: A Randomized Crossover Trial; Sci. Rep. 8 (2018) 10378. DOI: 10.1038/s41598-018-28723-0
  244. Haptonstall, K.P., Y. Choroomi, R. Moheimani, K. Nguyen, E. Tran, K. Lakhani, I. Ruedisueli, J. Gornbein, and H.R. Middlekauff: Differential Effects of Tobacco Cigarettes and Electronic Cigarettes on Endothelial Function in Healthy Young People; Am. J. Physiol. Heart Circ. Physiol. 319 (2020) H547–H556. DOI: 10.1152/ajpheart.00307.2020
  245. Kim, C.Y., Y.J. Paek, H.G. Seo, Y.S. Cheong, C.M. Lee, S.M. Park, D.W. Park, and K. Lee: Dual Use of Electronic and Conventional Cigarettes Is Associated with Higher Cardiovascular Risk Factors in Korean Men; Sci. Rep. 10 (2020) 5612. DOI: 10.1038/s41598-020-62545-3
  246. Moheimani, R.S., M. Bhetraratana, K.M. Peters, B.K. Yang, F. Yin, J. Gornbein, J.A. Araujo, and H.R. Middlekauff: Sympathomimetic Effects of Acute E-Cigarette Use: Role of Nicotine and Non-Nicotine Constituents; J. Am. Heart Assoc. 6 (2017) e006579. DOI: 10.1161/jaha.117.006579
  247. Moheimani, R.S., M. Bhetraratana, F. Yin, K.M. Peters, J. Gornbein, J.A. Araujo, and H.R. Middlekauff: Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk; JAMA Cardiol. 2 (2017) 278–284. DOI: 10.1001/jamacardio.2016.5303
  248. Oliveri, D., Q.W. Liang, and M. Sarkar: Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm between Adult E-Vapor Users and Adult Cigarette Smokers; Nicotine Tob. Res. 22 (2020) 1114–1122. DOI: 10.1093/ntr/ntz185
  249. Stokes, A.C., W. Xie, A.E. Wilson, H. Yang, O.A. Orimoloye, A.F. Harlow, J.L. Fetterman, A.P. DeFilippis, E.J. Benjamin, R.M. Robertson, A. Bhatnagar, N.M. Hamburg, and M.J. Blaha: Association of Cigarette and Electronic Cigarette Use Patterns with Levels of Inflammatory and Oxidative Stress Biomarkers among US Adults: Population Assessment of Tobacco and Health Study; Circulation 143 (2021) 869–871. DOI: 10.1161/circulationaha.120.051551
  250. Hecht, S.S., S.G. Carmella, D. Kotandeniya, M.E. Pillsbury, M. Chen, B.W.S. Ransom, R.I. Vogel, E. Thompson, S.E. Murphy, and D.K. Hatsukami: Evaluation of Toxicant and Carcinogen Metabolites in the Urine of E-Cigarette Users Versus Cigarette Smokers; Nicotine Tob. Res. 17 (2015) 704–709. DOI: 10.1093/ntr/ntu218
  251. Kim, H.-J. and H.-S. Shin: Determination of Tobacco-Specific Nitrosamines in Replacement Liquids of Electronic Cigarettes by Liquid Chromatography-Tandem Mass Spectrometry; J. Chromatogr. A 1291 (2013) 48–55. DOI: 10.1016/j.chroma.2013.03.035
  252. Lizhnyak, P.N., B. Noggle, L. Wei, J. Edmiston, E. Becker, R.A. Black, and M. Sarkar: Understanding Heterogeneity among Individuals Who Smoke Cigarettes and Vape: Assessment of Biomarkers of Exposure and Potential Harm among Subpopulations from the PATH Wave 1 Data; Harm Reduct. J. 19 (2022) 90. DOI: 10.1186/s12954-022-00673-x
  253. Pulvers, K., N.L. Nollen, M. Rice, C.H. Schmid, K. Qu, N.L. Benowitz, and J.S. Ahluwalia: Effect of Pod E-Cigarettes vs Cigarettes on Carcinogen Exposure among African American and Latinx Smokers A Randomized Clinical Trial; JAMA Netw. Open 3 (2020) 13. DOI: 10.1001/jamanetworkopen.2020.26324
  254. Shahab, L., M.L. Goniewicz, B.C. Blount, J. Brown, A. McNeill, K.U. Alwis, J. Feng, L. Wang, and R. West: Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-Sectional Study; Ann. Intern. Med. 166 (2017) 390–400. DOI: 10.7326/M16-1107
  255. Chitteti, R., J.P. Zuniga-Hertz, J.A. Masso-Silva, J. Shin, I. Niesman, C.M. Bojanowski, A.J. Kumar, M. Hepokoski, L.E. Crotty Alexander, H.H. Patel, and D.M. Roth: E-Cigarette-Induced Changes in Cell Stress and Mitochondrial Function; Free Radical Biology and Medicine 228 (2025) 329–338. DOI: 10.1016/j.freeradbiomed.2025.01.004
  256. Kanithi, M., S. Junapudi, S.I. Shah, A. Matta Reddy, G. Ullah, and B. Chidipi: Alterations of Mitochondrial Network by Cigarette Smoking and E-Cigarette Vaping; Cells 11 (2022) 1688. DOI: 10.3390/cells11101688
  257. Tommasi, S., N. Pabustan, M. Li, Y. Chen, K.D. Siegmund, and A. Besaratinia: A Novel Role for Vaping in Mitochondrial Gene Dysregulation and Inflammation Fundamental to Disease Development; Sci. Rep. 11 (2021) 22773. DOI: 10.1038/s41598-021-01965-1
  258. Kim, M.D., N. Baumlin, A. Guerrero-Cignarella, A. Schmid, C. Aguiar, M. Mohiuddin, J.S. Dennis, J.S. Ahluwalia, E.L. Leavens, N. Nollen, M. Campos, and M. Salathe: Persistence of Airway Inflammation in Smokers Who Switch to Electronic Cigarettes; ERJ Open Res. 8 (2022) 00117–02022. DOI: 10.1183/23120541.00117-2022
  259. Mainous III, A.G., S. Yadav, Y.-R. Hong, and J. Huo: E-Cigarette and Conventional Tobacco Cigarette Use, Dual Use, and C-Reactive Protein; J. Am. Coll. Cardiol. 75 (2020) 2271–2273. DOI: 10.1016/j.jacc.2020.02.061
  260. Moon, J., H. Lee, M. Kong, H. Kim, and Y. Oh: Association between Electronic Cigarette Use and Levels of High-Sensitivity C-Reactive Protein and Uric Acid; Asia Pac. J. Public Health 32 (2020) 35–41. DOI: 10.1177/1010539519899777
  261. Perez, M.F., E.L. Mead, N.C. Atuegwu, E.M. Mortensen, M. Goniewicz, and C. Oncken: Biomarkers of Toxicant Exposure and Inflammation among Women of Reproductive Age Who Use Electronic or Conventional Cigarettes; J. Womens Health 30 (2021) 539–550. DOI: 10.1089/jwh.2019.8075
  262. Yao, Z., E. Tasdighi, Z.A. Dardari, J. Erhabor, K.K. Jha, N. Osuji, T. Rajan, E. Boakye, C.J. Rodriguez, J.A.C. Lima, S. Judd, T. Feldman, J.A. Fialkow, V.S. Ramachandran, O. El Shahawy, E.J. Benjamin, A. Bhatnagar, A.P. DeFilippis, K. Nasir, and M.J. Blaha: Use of E-Cigarette, Traditional Cigarettes, and C-Reactive Protein: The Cross Cohort Collaboration; Am. Heart J. 280 (2025) 1–6. DOI: 10.1016/j.ahj.2024.10.012
  263. Williams, M., A. Villarreal, K. Bozhilov, S. Lin, and P. Talbot: Metal and Silicate Particles Including Nanoparticles Are Present in Electronic Cigarette Cartomizer Fluid and Aerosol; PLOS ONE 8 (2013) e57987. DOI: 10.1371/journal.pone.0057987
  264. Sakamaki-Ching, S., M. Williams, M. Hua, J. Li, S.M. Bates, A.N. Robinson, T.W. Lyons, M.L. Goniewicz, and P. Talbot: Correlation between Biomarkers of Exposure, Effect and Potential Harm in the Urine of Electronic Cigarette Users; BMJ Open Respir. Res. 7 (2020) e000452. DOI: 10.1136/bmjresp-2019-000452
  265. Tommasi, S., H. Blumenfeld, and A. Besaratinia: Vaping Dose, Device Type, and E-Liquid Flavor Are Determinants of DNA Damage in Electronic Cigarette Users; Nicotine Tob. Res. 25 (2023) 1145–1154. DOI: 10.1093/ntr/ntad003
  266. Navas-Acien, A., I. Martinez-Morata, M. Hilpert, A. Rule, D. Shimbo, and N.J. LoIacono: Early Cardiovascular Risk in E-Cigarette Users: The Potential Role of Metals; Curr. Environ. Health Rep. 7 (2020) 353–361. DOI: 10.1007/s40572-020-00297-y, Correction in Curr. Environ. Health Rep. 7 (2020) 362. DOI: 10.1007/s40572-020-00302-4
  267. Lamas, G.A., A. Bhatnagar, M.R. Jones, K.K. Mann, K. Nasir, M. Tellez-Plaza, F. Ujueta, A. Navas-Acien, E.a.P. American Heart Association Council on, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, Council on Peripheral Vascular Disease, and Council on the Kidney in Cardiovascular Disease: Contaminant Metals as Cardiovascular Risk Factors: A Scientific Statement from the American Heart Association; J. Am. Heart Assoc. 12 (2023) e029852. DOI: 10.1161/JAHA.123.029852
  268. Besaratinia, A.: Electronic Cigarette-Derived Metals: Exposure and Health Risks in Vapers; Chem. Res. Toxicol. 38 (2025) 542–556. DOI: 10.1021/acs.chemrestox.4c00520
  269. Antonini, J.M., M.D. Taylor, A.T. Zimmer, and J.R. Roberts: Pulmonary Responses to Welding Fumes: Role of Metal Constituents; J. Toxicol. Environ. Health A 67 (2004) 233–249. DOI: 10.1080/15287390490266909
  270. Wu, L., F. Cui, J. Ma, Z. Huang, S. Zhang, Z. Xiao, J. Li, X. Ding, and P. Niu: Associations of Multiple Metals with Lung Function in Welders by Four Statistical Models; Chemosphere 298 (2022) 134202. DOI: 10.1016/j.chemosphere.2022.134202
  271. Zhang, J., Y. Hu, X. Wang, X. Ding, X. Cen, B. Wang, S. Yang, Z. Ye, W. Qiu, W. Chen, and M. Zhou: Associations of Personal PM2.5-Bound Heavy Metals and Heavy Metal Mixture with Lung Function: Results from a Panel Study in Chinese Urban Residents; Chemosphere 364 (2024) 143084. DOI: 10.1016/j.chemosphere.2024.143084
  272. Jin, Z., W. Sun, J. Huang, and G. Wang: Heavy Metals and Their Relationships with Lung Function and Airway Inflammation: Insights from a Population-Based Study; J. Transl. Med. 23 (2025) 642. DOI: 10.1186/s12967-025-06538-8
  273. Zhu, Y. and M. Costa: Metals and Molecular Carcinogenesis; Carcinogenesis 41 (2020) 1161–1172. DOI: 10.1093/carcin/bgaa076
  274. International Agency for Research on Cancer (IARC): Cobalt, Antimony Compounds, and Weapons-Grade Tungsten Alloy; IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Vol. 131, IARC, Lyon, France, 2023, 594 pp. ISBN: 978-92-832-0171-7. Available at: https://www.ncbi.nlm.nih.gov/books/NBK598318 (accessed June 23, 2026).
  275. Morabito, J.A., M.R. Holman, Y.S. Ding, X. Yan, M. Chan, D. Chafin, J. Perez, M.I. Mendez, R.B. Cardenas, and C. Watson: The Use of Charcoal in Modified Cigarette Filters for Mainstream Smoke Carbonyl Reduction; Regul. Toxicol. Pharmacol. 86 (2017) 117–127. DOI: 10.1016/j.yrtph.2017.02.019
  276. Kang, Y.-J., H.-K. Jo, M.-H. Jang, X. Ma, Y. Jeon, K. Oh, and J.-I. Park: A Brief Review of Formaldehyde Removal through Activated Carbon Adsorption; Appl. Sci. 12 (2022) 5025. DOI: 10.3390/app12105025
  277. Branton, P.J., K.G. McAdam, D.B. Winter, C. Liu, M.G. Duke, and C.J. Proctor: Reduction of Aldehydes and Hydrogen Cyanide Yields in Mainstream Cigarette Smoke Using an Amine Functionalised Ion Exchange Resin; Chem. Cent. J. 5 (2011) 15. DOI: 10.1186/1752-153X-5-15
  278. de Falco, B., A. Petridis, P. Paramasivan, A.D. Troise, A. Scaloni, Y. Deeni, W.E. Stephens, and A. Fiore: Reducing Toxic Reactive Carbonyl Species in E-Cigarette Emissions: Testing a Harm-Reduction Strategy Based on Dicarbonyl Trapping; RSC Adv. 10 (2020) 21535–21544. DOI: 10.1039/d0ra02138e
  279. Kosmider, L., A. Sobczak, M. Fik, J. Knysak, M. Zaciera, J. Kurek, and M.L. Goniewicz: Carbonyl Compounds in Electronic Cigarette Vapors: Effects of Nicotine Solvent and Battery Output Voltage; Nicotine Tob. Res. 16 (2014) 1319–1326. DOI: 10.1093/ntr/ntu078
  280. Jensen, R.P., W. Luo, J.F. Pankow, R.M. Strongin, and D.H. Peyton: Hidden Formaldehyde in E-Cigarette Aerosols; N. Engl. J. Med. 372 (2015) 392–394. DOI: 10.1056/NEJMc1413069
  281. Brown, C.J. and J.M. Cheng: Electronic Cigarettes: Product Characterisation and Design Considerations; Tob. Control 23 Suppl 2 (2014) ii4–10. DOI: 10.1136/tobaccocontrol-2013-051476
  282. Dibaji, S.A.R., B. Oktem, L. Williamson, J. DuMond, T. Cecil, J.P. Kim, S. Wickramasekara, M. Myers, and S. Guha: Characterization of Aerosols Generated by High-Power Electronic Nicotine Delivery Systems (ENDS): Influence of Atomizer, Temperature and PG:VG Ratios; PLOS ONE 17 (2022) e0279309. DOI: 10.1371/journal.pone.0279309
  283. Korzun, T., M. Lazurko, I. Munhenzva, K.C. Barsanti, Y. Huang, R.P. Jensen, J.O. Escobedo, W. Luo, D.H. Peyton, and R.M. Strongin: E-Cigarette Airflow Rate Modulates Toxicant Profiles and Can Lead to Concerning Levels of Solvent Consumption; ACS Omega 3 (2018) 30–36. DOI: 10.1021/acsomega.7b01521
  284. Staal, Y.C., S. van de Nobelen, A. Havermans, and R. Talhout: New Tobacco and Tobacco-Related Products: Early Detection of Product Development, Marketing Strategies, and Consumer Interest; JMR Public Health Surveill. 4 (2018) e55. DOI: 10.2196/publichealth.7359
  285. Smith, C.J. and P. Martin: Conducting Clinical Evaluations in Human Smokers Switching to Reduced-Toxicity Cigarettes; in: Toxicological Evaluation of Tobacco Products, Vol. 28, Proc. 56th Tobacco Science Research Conference (TSRC), 2002, Lexington, KY, USA, TSRC, 2002, pp. 166–190.
  286. Lin, X., Y. Fan, X. Wang, M. Chi, X. Li, X. Zhang, and D. Sun: Correlation between Tumor Necrosis Factor-A and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function; Am. J. Med. Sci. 354 (2017) 388–394. DOI: 10.1016/j.amjms.2017.06.004
  287. Maskey-Warzęchowska, M., P. Nejman-Gryz, K. Osinka, P. Lis, K. Malesa, K. Górska, and R. Krenke: Acute Response to Cigarette Smoking Assessed in Exhaled Breath Condensate in Patients with Chronic Obstructive Pulmonary Disease and Healthy Smokers; in: Respiratory Treatment and Prevention, edited by M. Pokorski, Springer International Publishing, Cham, ISBN: 978-3-319-44488-8, 2017, pp. 73–80. DOI: 10.1007/5584_2016_43
  288. Garey, K.W., M.M. Neuhauser, R.A. Robbins, L.H. Danziger, and I. Rubinstein: Markers of Inflammation in Exhaled Breath Condensate of Young Healthy Smokers; Chest 125 (2004) 22–26. DOI: 10.1378/chest.125.1.22
  289. Menzel, A., H. Samouda, F. Dohet, S. Loap, M.S. Ellulu, and T. Bohn: Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes?; Antioxidants 10 (2021) 414. DOI: 10.3390/antiox10030414
  290. Li, H., X. Xie, L. Tang, C. Chen, and J. Li: Multi-Omics Signatures of Chronic Inflammation across Immune-Related Disease States; Front. Immunol. 17 (2026) 1753156. DOI: 10.3389/fimmu.2026.1753156
  291. Russell, M.A.H.: Low-Tar Medium-Nicotine Cigarettes: A New Approach to Safer Smoking; Br. Med. J. 1 (1976) 1430–1433. DOI: 10.1136/bmj.1.6023.1430
DOI: https://doi.org/10.2478/cttr-2026-0009 | Journal eISSN: 2719-9509 (formerly 1612-9237)
Language: English, French, German
Page range: 116 - 147
Submitted on: Mar 9, 2026
Accepted on: Jun 18, 2026
Published on: Aug 31, 2026
Published by: Beiträge zur Tabakforschung GmbH
In partnership with: Paradigm Publishing Services

© 2026 Carr J. Smith, Thomas A. Perfetti, published by Beiträge zur Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.